Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Cervical Neoplasia
Interventions
DEVICE

Treatment of cervical neoplasia by thermal ablation

Women screened for cervical cancer by visual inspection with diluted acetic acid (VIA) presenting lesions eligible for ablative treatment were treated by thermal ablation. The treatment consisted in applying the probe on the lesion for 45 seconds at 100 degrees Celsius, with one to up to five applications depending on the lesion size. Following treatment, women were inquired about the pain level during the procedure, their satisfaction level of the procedure and whether they would recommend this treatment to their relatives. Women had a follow-up visit at 6 weeks to assess any complication of the procedure. Women were rescreened at 12 months, to evaluate the cure rate and any long-term adverse events.

Trial Locations (1)

2210

Kamenge University Hospital, Bujumbura

All Listed Sponsors
collaborator

Kamenge University Hospital, Burundi University, Burundi

UNKNOWN

lead

International Agency for Research on Cancer

OTHER

NCT05211271 - Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia | Biotech Hunter | Biotech Hunter